Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Roche_Holding_AG
|
| gptkbp:collaboratesWith |
various healthcare organizations
|
| gptkbp:contributedTo |
personalized medicine
|
| gptkbp:develops |
diagnostic solutions
|
| gptkbp:employs |
engineers
researchers scientists |
| gptkbp:engagesIn |
clinical trials
|
| gptkbp:established |
1995
|
| gptkbp:focus |
in vitro diagnostics
|
| gptkbp:foundedBy |
gptkb:Roche_Holding_AG
|
| gptkbp:hasPart |
gptkb:Roche_Diagnostics
laboratories research facilities distribution centers manufacturing facilities sales teams marketing teams support teams |
| gptkbp:headquarters |
gptkb:Pleasanton,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Roche Molecular Systems
|
| gptkbp:industry |
medical diagnostics
|
| gptkbp:isActiveIn |
genetic testing
point-of-care testing infectious disease diagnostics oncology diagnostics blood screening transplant diagnostics women's health diagnostics |
| gptkbp:isHeadquarteredIn |
gptkb:Pleasanton,_California
|
| gptkbp:isInvolvedIn |
quality assurance
patient advocacy product development market access disease prevention health economics regulatory affairs therapeutic monitoring healthcare_innovation healthcare_research biomarker_discovery |
| gptkbp:isKnownFor |
innovative diagnostics
|
| gptkbp:isPartOf |
gptkb:Roche_Group
|
| gptkbp:keyPeople |
gptkb:Thomas_Schinecker
|
| gptkbp:offers |
HCV tests
HIV tests HPV tests COVID-19_tests |
| gptkbp:operatesIn |
global market
|
| gptkbp:parentCompany |
gptkb:Roche_Holding_AG
|
| gptkbp:products |
molecular diagnostic tests
|
| gptkbp:provides |
testing services
|
| gptkbp:specializesIn |
PCR_technology
|
| gptkbp:website |
www.roche.com
|